In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 10, 2002, Pages 3323-3326

  Afeltra, Javier ^a   Dannaoui, Eric ^a   Meis, Jacques F G M ^a   Rodriguez Tudela, Juan L ^a   Verweij, Paul E ^a   Roilides, Emmanuel ^a   Maglaveras, Nicos ^a   Abrahamsen, Tore ^a   Gaustad, Peter ^a   Denning, David W ^a   Petrikkos, George ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBACONAZOLE; AMPHOTERICIN B; PENTAMIDINE; POSACONAZOLE; RAVUCONAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG POTENTIATION; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; FUNGUS ISOLATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MODEL; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DRUG SYNERGISM; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; PENTAMIDINE; SCEDOSPORIUM;

EID: 0036784058     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.10.3323-3326.2002     Document Type: Article

References (30)

1. Acute, rapidly progressive renal failure with simultaneous use of amphotericin B and pentamidine
2. Effect of pentamidine on the growth of Cryptococcus neoformans
3. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature
4. Use of a new bioassay to study pentamidine pharmacokinetics
5. In vitro activities of four novel triazoles against Scedosporium spp
6. Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusarium: Demonstration of in vitro synergy between rifabutin and amphotericin B
7. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum
8. In vitro antimicrobial activity of aromatic diamidines and diimidazolines related to pentamidine
9. Distribution of pentamidine in patients with AIDS
10. Antimicrobial combinations
11. Super in vitro synergy between inhibitors of dihydrofolate reductase and inhibitors of other folate-requiring enzymes: The critical role of polyglutamylation
12. Prevention of infection due to Pneumocystis carinii
13. The search for synergy: A critical review from a response surface perspective
14. Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine
15. Fungicidal versus fungistatic activity of terbinafine and itraconazole: An in vitro comparison
16. In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp
17. Enhancement of the in vitro activity of amphotericin B against Aspergillus spp. by tetracycline analogs
18. Disseminated infection and colonization by Scedosporium prolificans: A review of 18 cases, 1990-1999
19. Effects of pentamidine isethionate on Saccharomyces cerevisiae
20. Potentiation of inhibition of wild-type and mutant human immunodeficiency virus type 1 reverse transcriptases by combinations of nonnucleoside inhibitors and D- and L-(β)-dideoxynucleoside triphosphate analogs
21. Synergistic effect of Ir-(COT)-pentamidine alizarin red and pentamidine, amphotericin B, and paromomycin on Leishmania donovani
22. In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans
23. Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibition
24. Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection
25. Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species
26. The effect of nebulised pentamidine on the concentration of intra-oral Candida albicans in HIV-infected patients
27. Pentamidine: A review
28. Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against intraconazole-susceptible and -resistant Aspergillus fitmigatus isolates
29. Drugs used in the chemotherapy of protozoal infections: Malaria